DBFANet: a dual-branch feature alignment network for automated detection of breast cancer bone metastasis.
1/5 보강
Bone scan imaging for the detection of bone metastasis of breast cancer has been widely adopted; however, noise, anatomy superimposition, and small size for early lesions will severely affect its pred
APA
Liu G, Lin Q, et al. (2026). DBFANet: a dual-branch feature alignment network for automated detection of breast cancer bone metastasis.. Physics in medicine and biology, 71(3). https://doi.org/10.1088/1361-6560/ae4166
MLA
Liu G, et al.. "DBFANet: a dual-branch feature alignment network for automated detection of breast cancer bone metastasis.." Physics in medicine and biology, vol. 71, no. 3, 2026.
PMID
41633044 ↗
Abstract 한글 요약
Bone scan imaging for the detection of bone metastasis of breast cancer has been widely adopted; however, noise, anatomy superimposition, and small size for early lesions will severely affect its prediction performance. In this work, we propose a new framework with two major contributions to solve the main problems existing in current deep-learning-based approaches.In this study, we put forward a new model called the dual branch feature alignment network (DBFANet) for automated breast cancer bone metastases detection in bone scintigraphy. DBFA-net adopts a dual-branch CNN-Transformer structure: the CNN branch focuses on the local details, while the Transformer branch learns the global context. In addition, we design a feature alignment module (FRAT), which employs the bi-directional cross-attention mechanism for the complementary feature from two branches. Moreover, we propose an enhanced multi-scale attention module (EMSA) based on the squeeze-and-excitation (SE) block for stronger multi-scale lesion representations with less background noise suppression.We validated our proposed model based on a bone scintigraphy dataset containing 5092 images. In terms of bone metastasis prediction, DBFANet achieved an accuracy, precision, and recall value of 93.1%, 84.6%, and 84.7%, respectively, all superior to previous models (such as ResNet-50, EfficientNet-V2, and MaxViT). The ablation study has shown that both FRAT and EMSA have individual effectiveness and complementary benefits. Finally, additional external validation was performed on a publicly available bone scintigraphy dataset (BS-80K).DBFANet shows the highest detection performance for bone metastasis detection from multiview bone scintigraphy images with imbalanced classes and noise in the image, and the feature alignment with enhanced multiscale attention of DBFANet provides a useful and precise tool for bone metastasis diagnosis in a nuclear medicine imaging scenario.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- m6A-Modified BASP1 Regulates IL6 Expression to Induce TAM Infiltration to Promote Gastric Cancer Progression.
- Real-world incidence, prevalence, and clinical impact of brain metastases in patients with ALK-positive metastatic non-small cell lung cancer treated with first-line ALK tyrosine kinase inhibitors.
- Efficacy and safety of short-course blinatumomab in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia.
- Effectiveness of the aspiration method in preventing delayed bleeding after gastric endoscopic submucosal dissection.
- Angiotensin‑converting enzyme 2 as an immune and prognostic biomarker in colorectal cancer.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.